Search - tctmd.com

Displaying 61 - 80 of 900

Sort: Relevancy | Date

News Daily News

Palliative Care in HF: Practical Advice From the HFSA

Caitlin E. Cox

December 05, 2024

News Conference News AHA 2024

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Yael L. Maxwell

November 20, 2024

News Conference News AHA 2024

First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2

Caitlin E. Cox

November 16, 2024

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News TCT 2024

Safety Retained When Fellows Lead Complex PCI Procedures

Yael L. Maxwell

October 27, 2024

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

News Daily News

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Caitlin E. Cox

October 08, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Daily News

Access to Cardiac PET Limited in Many Parts of the US

L.A. McKeown

September 13, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

AF After Cardiac Surgery More Likely in Men, More Deadly in Women

Yael L. Maxwell

August 21, 2024

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

Advertisement

Palliative Care in HF: Practical Advice From the HFSA

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Safety Retained When Fellows Lead Complex PCI Procedures

MACE in CV Trials: Has the Outcome Outlived Its Role?

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Access to Cardiac PET Limited in Many Parts of the US

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Platelet Hyperreactivity Score May Improve CVD Risk Detection

AF After Cardiac Surgery More Likely in Men, More Deadly in Women

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content